Ondansetron
Product Images NDC 52959-425

2 FDA label images from H. J. Harkins Company Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 52959-425). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by H. J. Harkins Company Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

52959 0425.jpg (52959 0425)

52959 0425.jpg (52959 0425)
This is a drug label panel for ONDANSETRON ODT 4mg tablets. It includes federal cautionary statements about prescription use and storage conditions, manufacturer information (Aurobindo), lot number OD0417008-A, and an instruction to take as directed by a physician. Multiple instances of the drug name, NDC, expiration date (04/30/20), lot number, and manufacturer NDC are listed in tabular format.*
FDA Label Image

Ondan.jpg (Ondan)

Ondan.jpg (Ondan)
Chemical structure diagram showing the molecular formula and bonds of ondansetron, the active ingredient in the product labeled by H. J. Harkins Company Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.